Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
History
Revenio was founded in 2006 and is headquartered in Toronto, Ontario. The company has grown rapidly since then and now has a significant presence in the United States, Europe, and Asia.
Mission
To provide healthcare providers and patients with technology, equipment and services that help them diagnose, prevent and treat disease quickly and accurately.
Vision
To be the global leader in health care technology, delivering innovative and effective care solutions that meet the needs and exceed the expectations of our customers.
